Boston Biopharma

Boston Biopharma Employees

12 people indexed:

Ahmad Hashem

Chief Executive Officer

0jz20v9@z10zju0xz326q9z.6v3 Sign up to see email

d91lqy7@z68l70y386xx3wk.q2q Sign up to see email
Antonella Fenech Ventura

Responsible Person – Boston Biopharma Limited

9qyldq.0095x28x@w53gl5590w0y0q9.d83 Sign up to see email

88gl81.47gk5kq4@95d1jdl302q9502.6g6 Sign up to see email
Asmaa Khalil

Regulatory Affairs Manager

q09wjd6@de0yw3wqz824x1x.jjf Sign up to see email

jdx67d9@377xf55x5d3dfu9.yqv Sign up to see email
Edita Mistinienė

Chief Scientific Officer

q0y4fyg7l20@v5vv7qf3w0qfu6d.6k2 Sign up to see email

dl0zxdk5qkx@542595z12d4l8ul.3dj Sign up to see email
Eric Egeland

Sales Representative – Alaska

v0k1jjxy@1wf7zz8x08q61jw.q1k Sign up to see email

98v20f1z@z67xqf2k2vkxz1j.51k Sign up to see email
Fyras Abdlkader

Business Development Manager

jzw9gw6xzq@x6vyz32uw2v2juv.5xv Sign up to see email

584j79j9v8@qwz2256x870433x.939 Sign up to see email
Kaldun Essa

Regional Manager – MENA

jq5f2@qf3z6xxjvx43z22.x6w Sign up to see email

fj545@40gdqf2x5gzxd21.uqf Sign up to see email
Kathy Clark

Corporate and Social Responsibility

efuv9z@820y6qfjev3gwxw.vuy Sign up to see email

2euzyx@yyzx0ew10uddwqe.1wy Sign up to see email
Patricio Fleury

Business Development Manager, LATAM

1z2d6xk@53v1q10w5z6kg6w.10z Sign up to see email

9qqzzv5@6537xx46d6j223z.9v8 Sign up to see email
Shuaib Hanief

Chief Business Officer

qyvk7zd@y8vuj9542yv228g.j3z Sign up to see email

ky9u160@g800y0llwqv67wx.31u Sign up to see email
Terry Clark

Chief Medical Officer

97wv1y@5107zgq8q2u586v.yy3 Sign up to see email

e918e2@94uwz255z0y1fj1.9xy Sign up to see email
Walid Fahmi

Country Manager - Oman

6v583e@1ll15yd0231vv7y.lu6 Sign up to see email

9d0150@z933e2veldyx9q5.4q1 Sign up to see email

Boston Biopharma Company Information

Boston Biopharma is a pharmaceutical company that specializes in developing and providing specialty medications across global markets, with a strong focus on emerging countries. The company is headquartered in the United States and operates a manufacturing and research and development site in Lithuania, as well as an office in Malta. Boston Biopharma’s product portfolio includes cancer medications, inhalation anesthesia, and cystic fibrosis treatments. Its cancer medications encompass luteinizing hormone-releasing hormone (LHRH) agonists and alkylating agents, which are approved for use in the European Union. The company also produces inhalation anesthetic agents in the United States, which are utilized for both the induction and maintenance of general anesthesia during surgeries. Additionally, Boston Biopharma provides cystic fibrosis medications that include CFTR potentiators, used alone or in combination to treat patients with specific genetic mutations. The company boasts a growing list of products available for licensing in various markets and has the capability to produce and export products from facilities certified in the US and EU. Boston Biopharma also partners with institutions in many countries to enhance local market expertise.

Report inaccurate information